|
1
|
Onishi H, Suyama K, Yamasaki A, Oyama Y,
Fujimura A, Kawamoto M and Imaizumi A: CD24 modulates
chemosensitivity of MCF-7 breast cancer cells. Anticancer Res.
37:561–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tramm T, Kim JY, Leibl S, Moinfar F and
Tavassoli FA: Expression of C-KIT, CD24, CD44s, and COX2 in benign
and non-invasive apocrine lesions of the breast. Virchows Arch.
469:285–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cremers N, Neeb A, Uhle T, Dimmler A,
Rothley M, Allgayer H, Fodde R, Sleeman JP and Thiele W: CD24 is
not required for tumor initiation and growth in murine breast and
prostate cancer models. PLoS One. 11:e01514682016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suyama K, Onishi H, Imaizumi A, Shinkai K,
Umebayashi M, Kubo M, Mizuuchi Y, Oda Y, Tanaka M, Nakamura M, et
al: CD24 suppresses malignant phenotype by downregulation of SHH
transcription through STAT1 inhibition in breast cancer cells.
Cancer Lett. 374:44–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Y, Song J, Jiang Y, Yu C and Ma Z:
Predictive value of CD44 and CD24 for prognosis and chemotherapy
response in invasive breast ductal carcinoma. Int J Clin Exp
Pathol. 8:11287–11295. 2015.PubMed/NCBI
|
|
6
|
Kwon MJ, Han J, Seo JH, Song K, Jeong HM,
Choi JS, Kim YJ, Lee SH, Choi YL and Shin YK: CD24 overexpression
is associated with poor prognosis in luminal A and triple-negative
breast cancer. PLoS One. 10:e01391122015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kapucuoğlu N, Bozkurt KK, Başpınar Ş,
Koçer M, Eroğlu HE, Akdeniz R and Akçil M: The clinicopathological
and prognostic significance of CD24, CD44, CD133, ALDH1 expressions
in invasive ductal carcinoma of the breast: CD44/CD24 expression in
breast cancer. Pathol Res Pract. 211:740–747. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu
KF, Zhao JM, Zhang GB and Zhang XG: Relationship between
co-stimulatory molecule B7-H3 expression and gastric carcinoma
histology and prognosis. World J Gastroenterol. 12:457–459. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: A novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zang X, Thompson RH, Al-Ahmadie HA, Serio
AM, Reuter VE, Eastham JA, Scardino PT, Sharma P and Allison JP:
B7-H3 and B7× are highly expressed in human prostate cancer and
associated with disease spread and poor outcome. Proc Natl Acad Sci
USA. 104:pp. 19458–19463. 2007, View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buck K, Hug S, Seibold P, Ferschke I,
Altevogt P, Sohn C, Schneeweiss A, Burwinkel B, Jäger D,
Flesch-Janys D, et al: CD24 polymorphisms in breast cancer: Impact
on prognosis and risk. Breast Cancer Res Treat. 137:927–937. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang LW and Lee CC: Cluster of
differentiation 24 expression is an independent prognostic factor
of adverse outcome in cervical carcinoma. Int J Gynecol Cancer.
23:325–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, et al: B7-H3: A
costimulatorymolecule for T cell activation and IFN-gamma
production. NatImmunol. 2:269–274. 2001.
|
|
16
|
King JB, von Furstenberg RJ, Smith BJ,
McNaughton KK, Galanko JA and Henning SJ: CD24 can be used to
isolate Lgr5+ putative colonic epithelial stem cells in
mice. Am J Physiol Gastrointest Liver Physiol. 303:G443–G452. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu B, Yang Y, Han S, Zhang L, Bai Y and
Fang X: Plasma CD24 as a novel useful biomarker in differentiating
hepatocellular carcinoma patients from normal individuals.
Hepatogastroenterology. 60:1245–1250. 2013.PubMed/NCBI
|
|
18
|
Sun X, Vale M, Leung E, Kanwar JR, Gupta R
and Krissansen GW: Mouse B7-H3 induces antitumor immunity. Gene
Ther. 10:1728–1734. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim J, Myers AC, Chen L, Pardoll DM,
Truong-Tran QA, Lane AP, McDyer JF, Fortuno L and Schleimer RP:
Constitutive and inducible expression of b7 family of ligands by
human airway epithelial cells. Am J Respir Cell Mol Biol.
33:280–289. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukushima A, Sumi T, Fukuda K, Kumagai N,
Nishida T, Yamazaki T, Akiba H, Okumura K, Yagita H and Ueno H:
B7-H3 regulates the development of experimental allergic
conjunctivitis in mice. Immunol Lett. 113:52–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
